Argentine scientists develop mosquito vaccine to cut dengue vector population

Researchers in Argentina are developing a vaccine targeting the dengue-transmitting mosquito, with antibodies that reduce insect survival after blood feeding. The approach is novel and at an early stage; efficacy and field impact remain unproven. If successful, it could offer a new tool against dengue transmission.